Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...
Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures. The FDA ...
MOUNTAIN VIEW, Calif., Feb. 27, 2012 /PRNewswire/ -- AccessClosure, Inc., the market leader in extravascular closure devices, announced today the FDA approval and US launch of the MynxGrip Vascular ...
Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. The MYNX CONTROL™ VENOUS VCD expands the Cordis portfolio of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results